Empresa Immune Pharmaceuticals Inc OTC Bulletin Board
Acciones
IMNP
US45254C1018
Farmacéuticos
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/11/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/02/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 3 713 | 0 | 0 | 100,00 % |
Acción B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Información de la empresa
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+31,37 % | 588 mil M | |
-2,60 % | 364 mil M | |
+20,83 % | 326 mil M | |
+5,69 % | 285 mil M | |
+14,83 % | 239 mil M | |
+9,93 % | 210 mil M | |
-6,95 % | 200 mil M | |
+10,77 % | 167 mil M | |
+0,10 % | 161 mil M |
- Bolsa de valores
- Acciones
- Acción FZRQ
- Acción IMNP
- Empresa Immune Pharmaceuticals Inc